VCNX logo

Vaccinex, Inc. (VCNX)

Profile

Full Name

Vaccinex, Inc.

Ticker

NASDAQ: VCNX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 9, 2018

Indexes

Not included

Website

http://www.vaccinex.com

Employees

23

Key Details

Price

$0.70(-29.29%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$601.00K(+5.44% YoY)

Annual EPS

-$8.88(+79.67% YoY)

PE ratio

-

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.70
    VCNX price is $0.70

    30-Day Relative Volume

    1.04
    VCNX 30-day relative volume is 1.04

    Price Performance

    Price Today change

    -29.29%
    VCNX price is down -29.29% today

    Price YTD change

    -28.57%
    VCNX price is down -28.57% since January 1st

    Price 1-year change

    -89.88%
    VCNX price is down -89.88% year-on-year

    Price 3-year change

    -99.7%
    VCNX price is down -99.7% over the past 3 years

    Price Range

    Price All-time high

    $2568.30
    VCNX price is currently -99.97% below its historical high of $2568.30

    Price 3-year low

    $0.25
    VCNX price is currently +180.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.87M
    VCNX market capitalization is $1.87 million

    Market cap 3-year change

    -96.08%
    VCNX market capitalization is down -96.08% over the past 3 years

    Market cap All-time high

    $149.46M
    VCNX market capitalization is currently -98.75% below its historical high of $149.46 million

    Market cap sector rank

    5.36%
    VCNX market capitalization is higher than 5.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +68.89%
    VCNX shares outstanding is up +68.89% year-on-year

    Shares Outstanding 3-Year Change

    +1217.22%
    VCNX shares outstanding is up +1217.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.86
    VCNX beta is 1.86

    200-day SMA

    $1.52
    VCNX price is currently -53.85% below its 200-day simple moving average

    50-day SMA

    $0.84
    VCNX price is currently -16.83% below its 50-day simple moving average

    RSI

    57.86
    VCNX 14-day relative strength index is 57.86

    Volume

    1.04
    VCNX 30-day relative volume is 1.04

    ATR

    $0.16
    VCNX average true range is $0.16

    10-day Historical Volatility

    114.99%
    VCNX 10-day historical volatility is 114.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $601.00K
    VCNX annual revenue is $601.00 thousand

    Revenue Analysts estimate

    $142.70M
    VCNX annual revenue is currently -99.58% lower than the consensus analysts' forecast

    Revenue 1-year change

    +5.44%
    VCNX annual revenue is up +5.44% year-on-year

    Revenue Sector rank

    10.63%
    VCNX annual revenue is higher than 10.63% of companies in Healthcare sector

    EPS

    EPS

    -$8.88
    VCNX annual earnings per share is -$8.88

    EPS Analysts estimate

    -
    VCNX annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +79.67%
    VCNX annual earnings per share is up +79.67% year-on-year

    EPS Sector rank

    14.12%
    VCNX annual earnings per share is higher than 14.12% of companies in Healthcare sector

    Profit

    Gross profit

    -
    VCNX annual gross profit value is unknown

    Gross margin

    -
    VCNX annual gross profit margin value is unknown

    Operating profit

    -$18.73M
    VCNX annual operating income is -$18.73 million

    Operating margin

    -3117.30%
    VCNX annual operating profit margin is -3117.30%

    Net income

    -$18.63M
    VCNX annual net profit is -$18.63 million

    Net margin

    -3100.50%
    VCNX annual net profit margin is -3100.50%

    Expenses

    Total expenses

    $19.34M
    VCNX annual total expenses is $19.34 million

    Operating expenses

    $19.34M
    VCNX annual total operating expenses is $19.34 million

    Cost of goods sold

    -
    VCNX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $6.79M
    VCNX annual SGA is $6.79 million

    Depreciation and amortization

    $94.00K
    VCNX annual depreciation & amortization is $94.00 thousand

    Interest expense

    $2000.00
    VCNX annual interest expense is $2000.00

    Income tax

    $0.00
    VCNX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$18.63M
    VCNX annual earnings before interest & taxes is -$18.63 million

    EBITDA

    -$18.54M
    VCNX annual EBITDA is -$18.54 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.60M
    VCNX annual total assets is $2.60 million

    Non current assets

    $65.00K
    VCNX annual long term assets is $65.00 thousand

    Current assets

    $2.53M
    VCNX annual total current assets is $2.53 million

    Cash and cash equivalents

    $1.11M
    VCNX annual cash & cash equivalents is $1.11 million

    Accounts receivable

    $838.00K
    VCNX annual accounts receivable is $838.00 thousand

    Inventory

    -
    VCNX annual inventory value is unknown

    Liabilities

    Total liabilities

    $5.08M
    VCNX annual total liabilities is $5.08 million

    Long term liabilities

    $0.00
    VCNX annual total long term liabilities is $0.00

    Current liabilities

    $5.08M
    VCNX annual total current liabilities is $5.08 million

    Accounts payable

    $3.96M
    VCNX annual accounts payable is $3.96 million

    Debt

    Total debt

    $25.00K
    VCNX annual total debt is $25.00 thousand

    Total debt 1-year change

    -89.88%
    VCNX annual total debt is down -89.88% year-on-year

    Long term debt

    -
    VCNX annual long term debt value is unknown

    Short term debt

    $25.00K
    VCNX annual short term debt is $25.00 thousand

    Equity & Capital

    Shareholders equity

    -$2.49M
    VCNX annual stockholders equity is -$2.49 million

    Book value

    -$4.15M
    VCNX annual book value is -$4.15 million

    Retained earnings

    -$358.56M
    VCNX annual retained earnings is -$358.56 million

    Working capital

    -$2.55M
    VCNX annual working capital is -$2.55 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$16.19M
    VCNX annual cash flow from operations is -$16.19 million

    Cash from operations 1-year change

    +24.29%
    VCNX annual cash flow from operations is up +24.29% year-on-year

    Cash from investing

    -$22.00K
    VCNX annual cash flow from investing activities is -$22.00 thousand

    Cash from investing 1-year change

    +67.16%
    VCNX annual cash flow from investing activities is up +67.16% year-on-year

    Cash from financing

    $15.78M
    VCNX annual cash flow from financing activities is $15.78 million

    Cash from financing 1-year change

    -4.88%
    VCNX annual cash flow from financing activities is down -4.88% year-on-year

    CAPEX

    CAPEX

    $22.00K
    VCNX annual capital expenditures is $22.00 thousand

    CAPEX 1-year change

    -67.16%
    VCNX annual capital expenditures is down -67.16% year-on-year

    Free Cash Flow

    Free cash flow

    -$16.21M
    VCNX annual free cash flow is -$16.21 million

    Free cash flow 1-year change

    +24.42%
    VCNX annual free cash flow is up +24.42% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    VCNX annual gross profit margin value is unknown

    Operating margin

    -3117.30%
    VCNX annual operating profit margin is -3117.30%

    Net margin

    -3100.50%
    VCNX annual net profit margin is -3100.50%

    ROA & ROE

    ROA

    -598.49%
    VCNX annual return on assets is -598.49%

    ROE

    748.95%
    VCNX annual return on equity is 748.95%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VCNX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VCNX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.45
    VCNX price to book ratio is -0.45

    PB ratio Sector rank

    11.58%
    VCNX price to book ratio is higher than 11.58% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.12
    VCNX price to sales ratio is 3.12

    PS ratio Sector rank

    49.67%
    VCNX price to sales ratio is higher than 49.67% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $791.62K
    VCNX enterprise value is $791.62 thousand

    Enterprise value Sector rank

    10.51%
    VCNX enterprise value is higher than 10.51% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.04
    VCNX EV/EBITDA is -0.04

    EV/EBITDA Sector rank

    66.2%
    VCNX EV/EBITDA is higher than 66.2% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.50
    VCNX annual current ratio is 0.50

    Quick ratio

    -
    VCNX annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.01
    VCNX annual debt to equity ratio is -0.01

    Interest coverage ratio

    -9316.00
    VCNX annual interest coverage ratio is -9316.00

    Risk & Stability

    Piotroski F-Score

    -
    VCNX piotroski f-score value is unknown

    Altman Z-Score

    -217.78
    VCNX altman z-score is -217.78

    Analyst ratings

    Recent major analysts updates

    Sep 25, 20 Oppenheimer
    Outperform
    Sep 23, 20 BTIG
    Neutral
    Sep 4, 18 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with VCNX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    • What is the ticker symbol for Vaccinex, Inc.?
    • Does Vaccinex, Inc. pay dividends?
    • What sector is Vaccinex, Inc. in?
    • What industry is Vaccinex, Inc. in?
    • What country is Vaccinex, Inc. based in?
    • When did Vaccinex, Inc. go public?
    • Is Vaccinex, Inc. in the S&P 500?
    • Is Vaccinex, Inc. in the NASDAQ 100?
    • Is Vaccinex, Inc. in the Dow Jones?
    • When was Vaccinex, Inc.'s last earnings report?
    • When does Vaccinex, Inc. report earnings?

    What is the ticker symbol for Vaccinex, Inc.?

    The ticker symbol for Vaccinex, Inc. is NASDAQ:VCNX

    Does Vaccinex, Inc. pay dividends?

    No, Vaccinex, Inc. does not pay dividends

    What sector is Vaccinex, Inc. in?

    Vaccinex, Inc. is in the Healthcare sector

    What industry is Vaccinex, Inc. in?

    Vaccinex, Inc. is in the Biotechnology industry

    What country is Vaccinex, Inc. based in?

    Vaccinex, Inc. is headquartered in United States

    When did Vaccinex, Inc. go public?

    Vaccinex, Inc.'s initial public offering (IPO) was on August 9, 2018

    Is Vaccinex, Inc. in the S&P 500?

    No, Vaccinex, Inc. is not included in the S&P 500 index

    Is Vaccinex, Inc. in the NASDAQ 100?

    No, Vaccinex, Inc. is not included in the NASDAQ 100 index

    Is Vaccinex, Inc. in the Dow Jones?

    No, Vaccinex, Inc. is not included in the Dow Jones index

    When was Vaccinex, Inc.'s last earnings report?

    Vaccinex, Inc.'s most recent earnings report was on November 18, 2024

    When does Vaccinex, Inc. report earnings?

    The next expected earnings date for Vaccinex, Inc. is July 29, 2025
    On this page